# Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma

> **NCT00430027** · NA · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 8 (actual)

## Conditions studied

- Esophageal Adenocarcinoma

## Interventions

- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00430027
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** This study was terminated due slow accrual.
- **Last updated:** 2013-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430027, "Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00430027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*